# Vascular Trial Associated Registry Pilot

Study · id `cardio:ct-nct07076082` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07076082](<https://clinicaltrials.gov/study/NCT07076082>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07076082

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

## Technical summary

Registry record NCT07076082. Randomized; no masking; primary purpose treatment. Start 2025-10-15 (actual); primary completion 2027-10-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 350 participants (planned count; ClinicalTrials.gov record NCT07076082, source copy `cardio:ctgov-nct07076082-2026-07-16`, retrieved 2026-10-31)
- Started: 2025-10-15 (actual) (ClinicalTrials.gov record NCT07076082, source copy `cardio:ctgov-nct07076082-2026-07-16`, retrieved 2026-10-31)
- Primary completion: 2027-10-30 (anticipated) (ClinicalTrials.gov record NCT07076082, source copy `cardio:ctgov-nct07076082-2026-07-16`, retrieved 2026-10-31)
- Completion: 2028-10-30 (anticipated) (ClinicalTrials.gov record NCT07076082, source copy `cardio:ctgov-nct07076082-2026-07-16`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT07076082, source copy `cardio:ctgov-nct07076082-2026-07-16`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07076082-2026-07-16`, retrieved 2026-10-31)

## The registry's words

- Brief title: Vascular Trial Associated Registry Pilot
- Acronym: VSTAR-P
- Condition: Peripheral Arterial Disease
- Intervention (Drug): Clopidogrel (Plavix) Pharmacogenetic Test Reagents
- Lead sponsor: Corewell Health West
- Lead sponsor class: OTHER
- Collaborator: Henry Ford Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as a collaborator: Henry Ford Hospital (`cardio:org-henry-ford-hospital`)

## Provenance

Content hash: cc0b6d178c93d061e75869de6ed3aa7cc7736bb7bdb69e29ee61de7fcca0147f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
